Results 111 to 120 of about 39,695 (260)

Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks. [PDF]

NPJ Precis Oncol
Ibrahim EIK, Laurén I, Veerman RE, Jönsson S, Ytterberg AJ, Lindqvist A, Mangsbo SM, Friberg LE.   +7 more
europepmc   +1 more source

Chronic HBV Infection Disrupts CCL5‐Secreting cNK Cells and Attenuates Liver Accumulation and Activation of DCs and HBV‐Specific T Cells

Advanced Science, EarlyView.
ADORA2A activation suppresses NFκB‐dependent CCL5 production in cNK cells during chronic HBV infection, disrupting intrahepatic DC recruitment and HBV‐specific CD8+ T‐cell differentiation and function. Targeting the ADORA2A/NFκB/CCL5 axis restores antiviral immunity and facilitates HBV clearance.
Ailu Yang, Yucan Wang, Yating Yu, Jing Wu, Cuiping Bao, Zixuan Wang, Qiuju Han, Zhigang Tian, Jian Zhang, Huajun Zhao   +9 more
wiley   +1 more source

Mucosal Delivery of Recombinant SARS-CoV-2 Spike Receptor-Binding Domain Antigen Containing Immune-Stimulating Peptides Induces Protective Immune Responses Against Viral Infection in huACE2 Mice. [PDF]

Vaccines (Basel)
Cho BH, Kim J, Jang YS.
europepmc   +1 more source

Nanovesicles With Mechanically Induced Adjuvanticity for Robust Melanoma Vaccination Toward Tumor‐Associated Macrophages

Advanced Science, EarlyView.
Rigidity‐tunable nanovesicle (P‐Pm) with mechanically induced adjuvanticity toward tumor‐associated macrophages (TAMs) was designed to engineer R848/gp100 antigen ‐loaded nanovaccine (P@Rg‐Pm), which achieved outstanding anti‐tumor outcomes in both therapeutic and preventive model of B16‐F10 melanoma.
Bangyue Luo, Liyan Qiu
wiley   +1 more source

mGem: Progress on the development of conjugate vaccines for <i>Cryptococcus neoformans</i> infections. [PDF]

mBio
Stempinski PR, Rodrigues Dos Santos Junior S, Casadevall A.   +2 more
europepmc   +1 more source

The Current Status of Simultaneous Vaccination of Children Aged 0-3 Years - China, 2022-2024. [PDF]

China CDC Wkly
Liu X, Liang Y, Zhang Z, Zhang S, Ye J, Hu R, Cao L, Peng H, Li L, Song Y, Yu W.   +10 more
europepmc   +1 more source

BCG HSP70 Reprograms Macrophages via Central Trained Immunity to Suppress Prostate Cancer

Advanced Science, EarlyView.
BCG‐derived HSP70 (Dnak) safely induces central trained immunity via epigenetic, metabolic, and O‐GlcNAcylation reprogramming of bone marrow progenitors, driving tumor‐associated macrophages toward an M1‐like phenotype to suppress prostate cancer. ABSTRACT Trained immunity offers a promising yet clinically challenging strategy for cancer immunotherapy,
Peng Liu, Kangkang Liu, Keruo Wang, Heyang Guan, Jiaming Fan, Taipeng Li, Jiaru Hao, Zeyuan Wang, Yongchao Yan, Jiatong Chen, Yuan Ma, Yang Yang, Yuanjie Niu   +12 more
wiley   +1 more source

Conjugate Vaccines for Streptococcus pneumoniae

Canadian Journal of Infectious Diseases, 1999
Peter R Paradiso
doaj   +1 more source

Targeted pneumococcal conjugate vaccination strategies for high-risk children. [PDF]

Hum Vaccin Immunother
Hart J, Toh ZQ, Do LAH, Mulholland K, Licciardi PV.   +4 more
europepmc   +1 more source

Pneumococcal Vaccines: The Impact of Conjugate Vaccine:Pneumococcal Vaccines: The Impact of Conjugate Vaccine [PDF]

Clinical Infectious Diseases, 2008
openaire   +1 more source